Literature DB >> 20433911

Disturbed synaptic connectivity in schizophrenia: convergence of genetic risk factors during neurodevelopment.

Akiko Hayashi-Takagi1, Akira Sawa.   

Abstract

The pathological mechanisms underlying schizophrenia are unclear. Although genetic susceptibility factors for schizophrenia likely influence neurodevelopmental processes, the onset of the disease is in adolescence and young adulthood. Here we review recent literatures implicating neurodevelopmental deficits in schizophrenia and discuss how genetic factors are involved in the processes toward onset of the disease. We emphasize the importance of postnatal glutamate synapse development in the pathology of the disorder. These genetic risk factors contribute to the process possibly in a synergistic manner. The notion of signal pathways involving more than one genetic factor is in accord with the multifactorial nature of schizophrenia. Copyright 2010. Published by Elsevier Inc.

Entities:  

Mesh:

Year:  2010        PMID: 20433911     DOI: 10.1016/j.brainresbull.2010.04.007

Source DB:  PubMed          Journal:  Brain Res Bull        ISSN: 0361-9230            Impact factor:   4.077


  21 in total

Review 1.  Advancing schizophrenia drug discovery: optimizing rodent models to bridge the translational gap.

Authors:  Judith Pratt; Catherine Winchester; Neil Dawson; Brian Morris
Journal:  Nat Rev Drug Discov       Date:  2012-06-22       Impact factor: 84.694

2.  Altered brain cannabinoid 1 receptor mRNA expression across postnatal development in the MAM model of schizophrenia.

Authors:  Felipe V Gomes; Jessica R Edelson; David W Volk; Anthony A Grace
Journal:  Schizophr Res       Date:  2018-04-26       Impact factor: 4.939

3.  Readdressing synaptic pruning theory for schizophrenia: Combination of brain imaging and cell biology.

Authors:  Akiko Hayashi-Takagi; Peter B Barker; Akira Sawa
Journal:  Commun Integr Biol       Date:  2011-03

4.  Quantitative systems pharmacology as an extension of PK/PD modeling in CNS research and development.

Authors:  Hugo Geerts; Athan Spiros; Patrick Roberts; Robert Carr
Journal:  J Pharmacokinet Pharmacodyn       Date:  2013-01-22       Impact factor: 2.745

5.  Pharmacological characterization of cultivated neuronal networks: relevance to synaptogenesis and synaptic connectivity.

Authors:  Peter Verstraelen; Isabel Pintelon; Rony Nuydens; Frans Cornelissen; Theo Meert; Jean-Pierre Timmermans
Journal:  Cell Mol Neurobiol       Date:  2014-04-19       Impact factor: 5.046

Review 6.  Genetics of schizophrenia from a clinicial perspective.

Authors:  Prachi Kukshal; B K Thelma; Vishwajit L Nimgaonkar; Smita N Deshpande
Journal:  Int Rev Psychiatry       Date:  2012-10

Review 7.  Defects in Bioenergetic Coupling in Schizophrenia.

Authors:  Courtney R Sullivan; Sinead M O'Donovan; Robert E McCullumsmith; Amy Ramsey
Journal:  Biol Psychiatry       Date:  2017-10-24       Impact factor: 13.382

Review 8.  Peripheral biomarkers revisited: integrative profiling of peripheral samples for psychiatric research.

Authors:  Akiko Hayashi-Takagi; Marquis P Vawter; Kazuya Iwamoto
Journal:  Biol Psychiatry       Date:  2013-10-18       Impact factor: 13.382

9.  Altered fronto-limbic activity in children and adolescents with familial high risk for schizophrenia.

Authors:  Sarah J Hart; Joshua Bizzell; Mary Agnes McMahon; Hongbin Gu; Diana O Perkins; Aysenil Belger
Journal:  Psychiatry Res       Date:  2013-03-06       Impact factor: 3.222

Review 10.  Synapse-specific contributions in the cortical pathology of schizophrenia.

Authors:  Saurav Seshadri; Mariela Zeledon; Akira Sawa
Journal:  Neurobiol Dis       Date:  2013-01-18       Impact factor: 5.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.